ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.650,03
0,00%
S&P 500
5.307,01
0,00%
US Dollar vs BRL
5,1299
-0,44%
Bitcoin
69.180,45
0,11%
Brent Oil
82,585
1,29%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Tetraphase Pharmaceuticals Inc (TTPH)

  7. Tetraphase Pharmaceuticals Inc (TTPH) Notícias

TTPH

Tetraphase Pharmaceuticals (TTPH)

Tetraphase Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TTPH
DataHoraFonteTítuloCódigoCompanhia
31/08/202016:20Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
31/08/202007:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
25/08/202007:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
25/08/202007:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
11/08/202015:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
31/07/202007:37Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202018:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202010:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202007:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/07/202007:01Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
28/07/202017:15GlobeNewswire Inc.La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/06/202010:50Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/06/202010:31Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202009:01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202008:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/06/202008:30GlobeNewswire Inc.La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.NASDAQ:TTPHTetraphase Pharmaceuticals Inc
22/06/202007:00Business WireTetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer & Notice to Me...NASDAQ:TTPHTetraphase Pharmaceuticals Inc
04/06/202010:22Business WireMelinta Therapeutics to Acquire Tetraphase PharmaceuticalsNASDAQ:TTPHTetraphase Pharmaceuticals Inc
03/06/202019:50PR Newswire (US)AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire TetraphaseNASDAQ:TTPHTetraphase Pharmaceuticals Inc
01/06/202018:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
01/06/202017:51Business WireTetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRxNASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/05/202009:43Business WireTetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased ConsiderationNASDAQ:TTPHTetraphase Pharmaceuticals Inc
29/05/202009:30PR Newswire (US)AcelRx Pharmaceuticals Announces Revised Merger Agreement with TetraphaseNASDAQ:TTPHTetraphase Pharmaceuticals Inc
27/05/202010:25Business WireTetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased ConsiderationNASDAQ:TTPHTetraphase Pharmaceuticals Inc
21/05/202022:55Business WireTetraphase Announces Determination of Superior Offer and Notice to AcelRxNASDAQ:TTPHTetraphase Pharmaceuticals Inc
07/05/202017:15Business WireTetraphase Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate DevelopmentsNASDAQ:TTPHTetraphase Pharmaceuticals Inc
07/05/202017:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
24/04/202017:09Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:TTPHTetraphase Pharmaceuticals Inc
20/04/202022:56PR Newswire (US)SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?NASDAQ:TTPHTetraphase Pharmaceuticals Inc
18/03/202014:52PR Newswire (US)Moore Kuehn Encourages DLPH, CSFL, TTPH, and FSCT Investors to Contact Law FirmNASDAQ:TTPHTetraphase Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TTPH

Seu Histórico Recente

ASX
BLG
Bluglass
TSXV
OJO
OJO Electric
LVCN
BPTNETH
Bit Public Talent Network
LSE
FL17
Mitsu Hc Cap.25
COIN
NOOGBP
LSE
RF99
Br.tel. 81 S
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados